Skip to main navigation Skip to search Skip to main content

Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice points and challenges

  • Natthawadee Laokulrath
  • , Mihir Gudi
  • , Syed Ahmed Salahuddin
  • , Angela Phek Yoon Chong
  • , Cristine Ding
  • , Jabed Iqbal
  • , Wei Qiang Leow
  • , Benjamin Yongcheng Tan
  • , Gary Tse
  • , Emad Rakha
  • , Puay Hoon Tan
  • Mahidol University
  • KK Women's and Children's Hospital
  • Singapore General Hospital
  • Singapore Health Services
  • Changi General Hospital
  • Duke-NUS Medical School
  • Prince of Wales Hospital Hong Kong
  • University of Nottingham
  • Luma Medical Centre

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Abstract

Human epidermal growth factor receptor 2 (HER2)-enriched breast cancer benefits significantly from anti-HER2 targeted therapies. This highlights the critical need for precise HER2 immunohistochemistry (IHC) interpretation serving as a triage tool for selecting patients for anti-HER2 regimens. Recently, the emerging eligibility of patients with HER2-low breast cancers for a novel HER2-targeted antibody-drug conjugate (T-DXd) adds challenges to HER2 IHC scoring interpretation, notably in the 0-1+ range, which shows high interobserver and interlaboratory staining platform variability. In this review, we navigate evolving challenges and suggest practical recommendations for HER2 IHC interpretation.
Original languageEnglish
Pages (from-to)371-382
Number of pages12
JournalHistopathology
Volume85
Issue number3
DOIs
Publication statusPublished - Sept 2024
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • breast cancer
  • HER2
  • HER2 scoring
  • HER2-low

Fingerprint

Dive into the research topics of 'Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice points and challenges'. Together they form a unique fingerprint.

Cite this